Antifungal susceptibility from the Spanish fungaemia surveillance multicentre study (FUNGEMYCA): are there any differences among ICU and non-ICU patients?

Ref ID: 17755


R. Zaragoza*, J. Pemán, E. Cantón, J. Camarena, J. Ayats, L. Torroba,
D. Navarro, G. Royo, J. Echavarria, J. Mart305;´nez, R. Guna, I.

Author address:

on behalf of the Spanish FUNGEMYCA group

Full conference title:

22nd European Congress of Clinical Microbiology and Infectious Diseases


Objectives: The introduction of new antifungal agents together with
the emergence of new fungal species with unknown susceptibility
requires surveillance for the detection of isolates with decreased
susceptibility to antifungal agents, especially in critical care setting, in
order to optimize the antifungal treatment. The aim of this study was to
determine whether there are any differences in the antifungal
susceptibility among ICU and non ICU adult patients in the age of
new agents.
Methods: Isolates from a recent bloodstream nosocomial fungemia
Spanish surveillance study were tested by the SensititreYeastOne (Y09)
method in each participating centre (Forty-three institutions participated
in the study) for susceptibility to eight antifungal agents. All isolates
identified and results of the Y09 test were sent to the central laboratory.
Clinical and microbiological variables were recorded. An univarite
analysis as performed using SPSS 15.00 package. A p value < 0.05 was considered significant.

Abstract Number: NULL

Conference Year: 2012

Link to conference website: NULL

New link: NULL

Conference abstracts, posters & presentations

Showing 10 posts of 17225 posts found.
  • Title





Our sponsors